Fes-deficient macrophages prime CD8 T cells to improve antitumor immunity, indicating potential for enhanced immunotherapy efficacy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Laight et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: